Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 346

    1.

    Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.

    Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD.

    Ann Intern Med. 1996 Oct 1;125(7):549-57.PMID: 8815753 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

    Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT.

    Ann Intern Med. 2001 Aug 21;135(4):248-57.PMID: 11511139 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

    Kidney Int. 2006 Aug;70(4):732-42. Epub 2006 Jul 5.PMID: 16820790 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Study on bolus cyclosphamide treatment for 64 cases of lupus nephritis]

    Liu G, Chen Y, Zuo C, Xie Q, Wang Z, Wang L, Lin M.

    Hua Xi Yi Ke Da Xue Xue Bao. 2001 Mar;32(1):129-30, 139. Chinese. PMID: 12733378 [PubMed - indexed for MEDLINE]Related articles

    5.

    Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.

    Cortés-Hernández J, Ordi-Ros J, Labrador M, Segarra A, Tovar JL, Balada E, Vilardell-Tarres M.

    Lupus. 2003;12(4):287-96.PMID: 12729052 [PubMed - indexed for MEDLINE]Related articles

    6.

    Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

    Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE.

    Lancet. 1992 Sep 26;340(8822):741-5.PMID: 1356175 [PubMed - indexed for MEDLINE]Related articles

    7.

    A controlled trial of pulse cyclophosphamide versus pulse methylprednisolone in severe lupus nephritis.

    Sesso R, Monteiro M, Sato E, Kirsztajn G, Silva L, Ajzen H.

    Lupus. 1994 Apr;3(2):107-12.PMID: 7920609 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mizoribine for the treatment of lupus nephritis in children and adolescents.

    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.

    Clin Nephrol. 2004 Dec;62(6):412-7.PMID: 15630899 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ]

    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.

    Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:19-25. Serbian. PMID: 12583309 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.

    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

    Arthritis Rheum. 2007 Mar;56(3):924-37.PMID: 17328070 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Sequential therapies for proliferative lupus nephritis.

    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.

    N Engl J Med. 2004 Mar 4;350(10):971-80.PMID: 14999109 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.

    Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN.

    N Engl J Med. 2000 Oct 19;343(16):1156-62.PMID: 11036121 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.

    Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ.

    Ann Intern Med. 1992 Jan 15;116(2):114-23.PMID: 1727614 [PubMed - indexed for MEDLINE]Related articles

    14.

    Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.

    Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.

    Nephrology (Carlton). 2005 Oct;10(5):504-10.PMID: 16221103 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).

    Calguneri M, Ozbalkan Z, Ozturk MA, Apras S, Ertenli AI, Kiraz S.

    Clin Rheumatol. 2006 Nov;25(6):782-8. Epub 2006 Mar 18.PMID: 16547692 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

    Chan TM, Tse KC, Tang CS, Mok MY, Li FK; Hong Kong Nephrology Study Group.

    J Am Soc Nephrol. 2005 Apr;16(4):1076-84. Epub 2005 Feb 23.PMID: 15728784 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.

    Mok CC, Ho CT, Siu YP, Chan KW, Kwan TH, Lau CS, Wong RW, Au TC.

    Am J Kidney Dis. 2001 Aug;38(2):256-64.PMID: 11479150 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.

    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.

    Clin Nephrol. 1994 Aug;42(2):71-8.PMID: 7955581 [PubMed - indexed for MEDLINE]Related articles

    19.

    Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.

    Contreras G, Tozman E, Nahar N, Metz D.

    Lupus. 2005;14 Suppl 1:s33-8.PMID: 15803929 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of proliferative lupus nephritis: a changing landscape.

    Adu D.

    Kidney Int. 2006 Aug;70(4):616-8.PMID: 16900218 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data